Form 4: OmniAb Director Carolyn R. Bertozzi Reports Stock Transactions
SEC Form 4 Filing
Director Carolyn R. Bertozzi reports the vesting of Restricted Stock Units (RSUs) and the acquisition of stock options in OmniAb, Inc.
Summary
- On June 18, 2024, Carolyn R. Bertozzi, a director of OmniAb, Inc. (OABI), reported transactions involving the company's stock.
- 20,000 shares of common stock were acquired through the vesting of Restricted Stock Units (RSUs).
- Additionally, 20,000 new RSUs were granted, and 40,000 stock options were acquired.
- Following these transactions, Bertozzi directly owns 37,770 shares of common stock, 55,538 RSUs, and 40,000 stock options.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing indicating standard compensation practices. The acquisition of stock options could be interpreted slightly positively, suggesting confidence, but it's not a major event.
Positives
- The acquisition of stock options by a director could be seen as a positive sign, indicating confidence in the company's future performance.
Future Outlook
The vesting of RSUs and exercisability of stock options are contingent upon future events, specifically the timing of the next annual meeting of stockholders or the first anniversary of the grant date.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors for insights into management's perspective on the company's stock.
Comparison to Industry Standards
- Stock option grants and RSU vesting are common forms of executive compensation in the biotechnology industry, used by companies like Amgen, Regeneron, and Gilead to align management's interests with those of shareholders.
- The vesting schedules and exercise prices are generally structured to incentivize long-term value creation.
Stakeholder Impact
- The transactions have a minor impact on shareholders by increasing the number of shares potentially available in the market upon exercise of options or vesting of RSUs.
Key Dates
| Date | Description |
|---|---|
| 06/23/2023 | Date of original RSU grant. |
| 06/18/2024 | Date of transaction: vesting of RSUs, grant of new RSUs, and acquisition of stock options. |
| 06/18/2034 | Expiration date of the stock options. |
| 06/20/2024 | Date of Form 4 signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.